A healthy diet, a healthy prostate? A brief commentary on the latest research on diet and prostate cancer.
A healthy diet, a healthy prostate? A brief commentary on the latest research on diet and prostate cancer.
复制标题
健康的饮食,健康的前列腺?
DOI:
10.1038/s41391-023-00651-9
复制
发表时间:
2023
影响因子:
4.8
通讯作者:
Freedland,StephenJ
中科院分区:
文献类型:
--
作者:
Galván,GloriaCecilia;Daniels,JamesP;Friedrich,NadineA;Das,Sanjay;Freedland,StephenJ
With global estimates of 1.4 million new diagnoses per year, prostate cancer (PC) is the second most common cancer and the fifth leading cause of death in men [1]. Recognizing and reversing the negative impacts of modifiable risk factors continues to be vital for improving morbidity and mortality in PC patients. As public opinion on diet is ever changing, novel questions about dietary regimens and supplementation, and their association with PC are being asked. Does the inflammatory potential of certain diets play any role in PC risk? Can carbohydrate restriction affect tumor growth? Are fasting-mimicking diets, which are effective in the management of type 2 diabetes and metabolic syndrome, safe for weight management in PC patients as well? And since most research on modifiable risk factors comes out of high-income countries, the risk factors for PC in low-and lowmiddle-income countries and dietary choices may not be the same, though to date this has been little studied. In addition, the search for a dietary supplement with preventative effects on PC has yet to yield favorable results [2]. Though clear evidence for recommended use is lacking, the search for PC prevention supplements continues with omega-3 fatty acids. Lastly, obesity is associated with the development of multiple chronic diseases, including coronary artery disease, hypertension, and diabetes [3, 4]. With the impact of obesity on health becoming a major problem globally, questions are also emerging. Does obesity increase the risk of PC? What is the relationship between obesity and biochemical recurrence (BCR)? Does weight management at initial diagnosis diminish the risk of BCR? We address these questions in the current collection, which summarizes eight recent manuscripts on diet and obesity as modifiable risk factors for PC published from March 2021 to May2022 in Prostate Cancer and Prostatic Diseases.1.“Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation–dependence on GPR120”[5]. In an orthotopic MycCaP model, docosahexaenoic acid (DHA) supplementation reduced tumor growth in mice fed an omega-3 fatty acid diet compared to mice fed an omega-6 fatty acid diet. DHA also lowered infiltration of M2 macrophages, M2 macrophage-dependent angiogenesis and activation of T cells. These effects are thought to be partially mediated by GPR120. These data provide some mechanistic understanding of the potential of omega-3 fatty acids to modify the tumor microenvironment and thereby slow PC growth.